4,045 Stocks in Quest Diagnostics Included (NYSE:DGX) Bought via Kentucky Retirement Methods Insurance coverage Accept as true with Fund

4,045 Stocks in Quest Diagnostics Included (NYSE:DGX) Bought via Kentucky Retirement Methods Insurance coverage Accept as true with Fund

[ad_1]

Kentucky Retirement Methods Insurance coverage Accept as true with Fund bought a brand new place in stocks of Quest Diagnostics Included (NYSE:DGXLoose Record) right through the 3rd quarter, in line with its most up-to-date disclosure with the SEC. The institutional investor bought 4,045 stocks of the scientific analysis corporate’s inventory, valued at roughly $493,000.

Different institutional traders have additionally added to or decreased their stakes within the corporate. Pacifica Companions Inc. received a brand new place in Quest Diagnostics right through the third quarter price roughly $25,000. Park Position Capital Corp raised its stake in Quest Diagnostics via 73.4% right through the second quarter. Park Position Capital Corp now owns 189 stocks of the scientific analysis corporate’s inventory price $27,000 after purchasing an extra 80 stocks right through the length. Chilton Capital Control LLC received a brand new place in Quest Diagnostics right through the first quarter price roughly $28,000. Alaska Everlasting Fund Corp received a brand new place in Quest Diagnostics right through the second quarter price roughly $37,000. In the end, Altshuler Shaham Ltd received a brand new place in Quest Diagnostics right through the second quarter price roughly $38,000. 87.76% of the inventory is owned via institutional traders and hedge finances.

Wall Side road Analysts Forecast Expansion

DGX has been the topic of a number of analyst studies. Piper Sandler larger their value purpose on Quest Diagnostics from $130.00 to $140.00 and gave the inventory a “impartial” score in a analysis be aware on Monday, November sixth. UBS Team larger their value purpose on Quest Diagnostics from $135.00 to $137.00 and gave the inventory a “impartial” score in a analysis be aware on Thursday, December seventh. Financial institution of The usa raised Quest Diagnostics from a “impartial” score to a “purchase” score and larger their value purpose for the inventory from $140.00 to $160.00 in a analysis be aware on Tuesday, December twelfth. TheStreet downgraded Quest Diagnostics from a “b-” score to a “c” score in a analysis be aware on Tuesday, October twenty fourth. In the end, Truist Monetary larger their value goal on Quest Diagnostics from $145.00 to $150.00 and gave the corporate a “cling” score in a analysis record on Wednesday. 9 analysis analysts have rated the inventory with a cling score and 3 have given a purchase score to the corporate. Consistent with knowledge from MarketBeat, the corporate has a consensus score of “Dangle” and a consensus value goal of $146.75.

View Our Newest Analysis Record on DGX

Quest Diagnostics Buying and selling Up 0.5 %

Stocks of DGX opened at $136.74 on Friday. The trade’s 50-day transferring reasonable value is $132.85 and its 200-day transferring reasonable value is $133.04. Quest Diagnostics Included has a twelve month low of $119.59 and a twelve month top of $158.34. The inventory has a marketplace cap of $15.37 billion, a PE ratio of 20.53 and a beta of 0.91. The corporate has a handy guide a rough ratio of one.01, a present ratio of one.12 and a debt-to-equity ratio of 0.61.

Quest Diagnostics (NYSE:DGXGet Loose Record) remaining posted its quarterly income knowledge on Tuesday, October twenty fourth. The scientific analysis corporate reported $2.22 income in keeping with percentage for the quarter, topping the consensus estimate of $2.19 via $0.03. The corporate had income of $2.30 billion for the quarter, in comparison to analysts’ expectancies of $2.27 billion. Quest Diagnostics had a internet margin of 8.21% and a go back on fairness of 15.80%. Quest Diagnostics’s income for the quarter used to be down 7.7% in comparison to the similar quarter remaining 12 months. Right through the similar length within the prior 12 months, the trade earned $2.36 income in keeping with percentage. On reasonable, equities analysts forecast that Quest Diagnostics Included will put up 8.71 EPS for the present fiscal 12 months.

Quest Diagnostics Dividend Announcement

The corporate additionally lately introduced a quarterly dividend, which will likely be paid on Wednesday, January thirty first. Shareholders of document on Wednesday, January seventeenth will likely be paid a $0.71 dividend. This represents a $2.84 annualized dividend and a yield of two.08%. The ex-dividend date is Tuesday, January sixteenth. Quest Diagnostics’s dividend payout ratio is these days 42.64%.

Quest Diagnostics Profile

(Loose Record)

Quest Diagnostics Included supplies diagnostic checking out, data, and products and services in the US and across the world. The corporate develops and delivers diagnostic data products and services, akin to ordinary checking out, non-routine and complex medical checking out, anatomic pathology checking out, and different diagnostic data products and services.

Learn Extra

Institutional Ownership by Quarter for Quest Diagnostics (NYSE:DGX)

Obtain Information & Rankings for Quest Diagnostics Day by day – Input your electronic mail deal with beneath to obtain a concise day by day abstract of the newest information and analysts’ scores for Quest Diagnostics and comparable corporations with MarketBeat.com’s FREE day by day electronic mail e-newsletter.

[ad_2]

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Back To Top
0
Would love your thoughts, please comment.x
()
x